Navigation Links
Labopharm Reports Results for Second Quarter Fiscal 2009
Date:8/7/2009

             - Quarter Marked by Launch of RYZOLT(TM) in U.S. -
           - Company to Submit Response to FDA for Novel Trazodone
                           Formulation Next Week -

LAVAL, QC, Aug. 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today reported its financial results for the second quarter ended June 30, 2009. All figures are in Canadian dollars unless otherwise stated.

"The second quarter of 2009 was highlighted by the U.S. commercial launch of RYZOLT(TM) by our marketing partner, Purdue Pharma," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We are encouraged by a number of aspects since the launch, including the growth of new prescriptions and the migration of patients to higher dosage strengths, which shows the product is being used as intended. However, the product was launched into a challenging market impacted by seasonality and a weakened U.S. economy. We continue to believe that RYZOLT offers physicians and patients an excellent option in the treatment of pain and are confident in the long-term prospects for our product in the U.S. market."

Added Mr. Howard-Tripp, "In Canada, our experience shows that with a strong marketing effort, our once-daily tramadol product performs well over time. In fact, in May and June of this year, our once-daily tramadol product was the best selling tramadol product in the country."

"We continue to prepare for commercialization of our novel trazodone formulation in the U.S.," concluded Mr. Howard-Tripp. "Following discussions with the U.S. Food and Drug Administration regarding its complete response letter and our API supplier's submission of its action plan to address deficiencies at its manufacturing facility, we intend to file our response with the FDA next week."

Financial Summary

<
'/>"/>
SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
2. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
3. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
4. Labopharm amends debt facility agreement with Hercules
5. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Labopharm announces details for first quarter results conference call and annual meeting
8. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
9. Labopharm to present at Cowen 29th Annual Health Care Conference
10. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
11. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Consistent premium price increases ... Vision Insurance industry in recent years; however, costs ... industry margins. From 2009 to 2014, industry revenue ... coverage for routine eye exams and other procedures, ... lens and refractive surgery. According to IBISWorld Industry ...
(Date:9/19/2014)... PA (PRWEB) September 19, 2014 Are ... tissue because of problems with seasonal allergies or sinus ... a much better alternative. , She conceived of ... with having a runny nose in public. Since it ... it promotes more sanitary conditions, particularly when cooking or ...
(Date:9/19/2014)... 19, 2014 BearCom, a nationwide ... detailed the key role played by instant, one-to-one ... the healthcare industry. , “In healthcare, speed ... – and in emergency situations, can save precious ... and death,” said Hugh Johnston, Product & Purchasing ...
(Date:9/19/2014)... On September 16, Camino Public Relations was ... Top Places to Work in PR Awards Luncheon at ... honorable mentions in two categories for “Multicultural Campaign” and ... Latina voices in the media. , "We're honored to ... of its efforts to improve the national conversation about ...
(Date:9/19/2014)... AZ (PRWEB) September 19, 2014 Hastings and ... 30 years in the industry, announces a record number of ... handles a wide variety of serious injury cases as well ... along with dog bite related accident cases and others. Having ... and Hastings has stood the test of time when it ...
Breaking Medicine News(10 mins):Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 3Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 4Health News:Camino Public Relations Honored for Raising Latina Voices in National Health Care, Immigration Debates 2Health News:Hastings And Hastings Announces a Record Number of Visitors to Its New Phoenix Personal Injury Website 2
... cut unnecessary biopsies, researchers say , WEDNESDAY, March 3 ... ways to treat and detect stubborn forms of prostate ... being presented this week at the annual Genitourinary Cancers ... of the prostate, kidney, bladder and testicles," Dr. Nicholas ...
... ... ... ... ...
... ... ... ... WASHINGTON , March 3 Michael A. Stephens , MPH, has joined the Association of ...
... commonly believed , WEDNESDAY, March 3 (HealthDay News) -- Early ... to a new study that may trigger a major change ... been believed that glaucoma -- the leading cause of blindness ... eye that damages the retina and optic nerve, so treatments ...
... ... ... ... ...
... MAYWOOD, Ill. -- A daily dose of vitamin D may ... winter, according to researchers at Loyola University Chicago Marcella Niehoff ... weather months when days are short and more time is ... problem despite the nutrient,s widely reported health benefits," said Sue ...
Cached Medicine News:Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 2Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 3Health News:New Drugs, Approaches Offer Hope Against Prostate Cancer 4Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 2Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 3Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 4Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 5Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 6Health News:Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health 2Health News:Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health 3Health News:Glaucoma Begins in Mid-Brain, Not in Eye, Research Shows 2Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 2Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 3Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 4Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 5Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 6Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 7Health News:Vitamin D lifts mood during cold weather months 2
(Date:9/19/2014)... September 19, 2014 According ... Type (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, ... Manifold, & Rotary) & Geography - Global Trends ... and segments the lyophilization market on the basis ... and projections of the market size of each ...
(Date:9/19/2014)... 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" ... and approved all parts required to build nine ... to manufacture the new PCT-based instrument system.  The ... for shipment by mid-October and that additional Barozyme ... rate of about one per week thereafter.  ...
(Date:9/19/2014)... N.Y. , Sept. 19, 2014  BioSpecifics Technologies Corp. ... in class collagenase-based products marketed as XIAFLEX ® in ... today that BioSpecifics, President, Tom Wegman , will present ... NewsMakers in the Biotech Industry Conference. The ... 3:00 p.m. EDT at the Millennium Broadway Hotel in ...
Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2
Hartman Mosquito forceps, straight, 3.5"....
Straight 20 mm serrated jaws. Ring handle with ratchet lock and dull finish. Overall length 3.9 inches...
Curved 21 mm serrated jaws. Ring handle with ratchet lock and dull finish. Most popular size or model. Overall length 4.7 inches...
Straight 22 mm serrated jaws. Ring handle with ratchet lock and dull finish. Overall length 4.9 inches...
Medicine Products: